壳聚糖
骨肉瘤
甲壳素
药物输送
生物相容性
骨癌
癌症
纳米技术
医学
化学
生物技术
癌症研究
材料科学
生物
生物化学
内科学
有机化学
作者
Parisa Maleki Dana,Jamal Hallajzadeh,Zatollah Asemi,Mohammad Alì Mansournia,Bahman Yousefi
标识
DOI:10.1016/j.ijbiomac.2020.12.058
摘要
Osteosarcoma has a high prevalence among children and adolescents. Common treatments of this disease are not promising enough. Molecular processes involved in the pathogenesis of osteosarcoma are not fully understood. Besides, the remnants of tumor cells after surgery can cause bone destruction and recurrence of the disease. Thus, there is a need to develop novel drugs or enhancing the currently-used drugs as well as identifying bone-repairing methods. Chitosan is a natural compound produced by the deacetylation of chitin. Research has shown that chitosan can be used in various fields due to its beneficial effects, such as biodegradability and biocompatibility. Regarding cancer, chitosan exerts several anti-tumor activities. Moreover, it can be used in diagnostic techniques, drug delivery systems, and cell culture methods. Herein, we aim to discuss the potential roles of chitosan in studying and treating osteosarcoma. We review the literature on chitosan's applications as a drug delivery system and how it can be combined with other substances to improve its ability of local drug delivery. We take a look into the studies concerning the possible benefits of chitosan in the field of bone tissue engineering and 3D culturing. Furthermore, anti-cancer activities of different compounds of chitosan are reviewed.
科研通智能强力驱动
Strongly Powered by AbleSci AI